These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37538847)
21. Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel Ghosh S; Chetia D; Gogoi N; Rudrapal M BioTechnologia (Pozn); 2021; 102(3):257-275. PubMed ID: 36606151 [TBL] [Abstract][Full Text] [Related]
22. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I. Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105 [TBL] [Abstract][Full Text] [Related]
23. Biflavonoids from Lokhande K; Nawani N; K Venkateswara S; Pawar S J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454 [TBL] [Abstract][Full Text] [Related]
24. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods. Ebrahimi M; Karami L; Alijanianzadeh M Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285 [TBL] [Abstract][Full Text] [Related]
25. A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus. Hossain FMA; Bappy MNI; Robin TB; Ahmad I; Patel H; Jahan N; Rabbi MGR; Roy A; Chowdhury W; Ahmed N; Prome AA; Rani NA; Khan P; Zinnah KMA J Biomol Struct Dyn; 2024 Aug; 42(12):6091-6107. PubMed ID: 37403283 [TBL] [Abstract][Full Text] [Related]
26. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies. Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960 [TBL] [Abstract][Full Text] [Related]
27. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents. Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141 [TBL] [Abstract][Full Text] [Related]
28. Temporal metabolic profiling of erythrocytes in mice infected with Babesia microti. Gong H; Rahman SU; Zhou K; Lin Z; Mi R; Huang Y; Zhang Y; Zhang Y; Jia H; Tang W; Xia C; Pandey K; Chen Z Microb Pathog; 2023 Feb; 175():105954. PubMed ID: 36574865 [TBL] [Abstract][Full Text] [Related]
29. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations. Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817 [TBL] [Abstract][Full Text] [Related]
31. Impact of Babesia microti infection on the initiation and course of pregnancy in BALB/c mice. Tołkacz K; Rodo A; Wdowiarska A; Bajer A; Bednarska M Parasit Vectors; 2021 Mar; 14(1):132. PubMed ID: 33653384 [TBL] [Abstract][Full Text] [Related]
32. Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study. Aatif M; Muteeb G; Alsultan A; Alshoaibi A; Khelif BY Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922914 [TBL] [Abstract][Full Text] [Related]
33. Effect of Date Palm ( Zia Q; Rehman MT; Hashmi MA; Siddiqui S; Bin Dukhyil A; Ahmed MZ; Jamal A; Banawas S; Almalki SG; Owais M; Aldhafeeri HQ; Ibrahim IM; Alturaiki W; AlAjmi MF; Alsieni M; Alqurashi YE Front Neurosci; 2022; 16():915122. PubMed ID: 35958986 [TBL] [Abstract][Full Text] [Related]
34. Chemical Characterization, Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087 [TBL] [Abstract][Full Text] [Related]
35. Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19. Rafi MO; Bhattacharje G; Al-Khafaji K; Taskin-Tok T; Alfasane MA; Das AK; Parvez MAK; Rahman MS J Biomol Struct Dyn; 2022 May; 40(8):3711-3730. PubMed ID: 33251975 [TBL] [Abstract][Full Text] [Related]
36. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics. Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103 [TBL] [Abstract][Full Text] [Related]
37. Protozoan Parasite Djokic V; Akoolo L; Primus S; Schlachter S; Kelly K; Bhanot P; Parveen N Front Microbiol; 2019; 10():1596. PubMed ID: 31354683 [TBL] [Abstract][Full Text] [Related]
38. Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation. Elekofehinti OO; Iwaloye O; Molehin OR; Famusiwa CD In Silico Pharmacol; 2021; 9(1):49. PubMed ID: 34395160 [TBL] [Abstract][Full Text] [Related]